Annual report pursuant to Section 13 and 15(d)

Prepaid Expenses and Other Current Assets (Tables)

v3.19.1
Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2018
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

December 31,

 

 

 

2018

 

 

2017

 

Prepaid research and development services

 

$

245

 

 

$

384

 

Prepaid insurance

 

 

200

 

 

 

279

 

Other prepaid expenses

 

 

20

 

 

 

62

 

Other receivable due from R-Pharm

 

 

 

 

 

251

 

NOL sale receivable (see Note 10)

 

 

6,732

 

 

 

 

Other current assets

 

 

54

 

 

 

91

 

Total prepaid expenses and other current assets

 

$

7,251

 

 

$

1,067